These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 37211635)

  • 1. Limitations of direct-to-consumer genetic testing for age-related macular degeneration.
    Shaheen AR; Uhr JH; Sridhar J; Yannuzzi NA
    Eur J Ophthalmol; 2023 Nov; 33(6):2059-2061. PubMed ID: 37211635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding and perception of direct-to-consumer genetic testing in Hong Kong.
    Hui VCC; Li HC; Chow JHK; Ng CSC; Lui CYW; Fung JLF; Mak CCY; Chung BHY; Lau KK
    J Genet Couns; 2021 Dec; 30(6):1640-1648. PubMed ID: 33938075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct-to-consumer personal genome testing for age-related macular degeneration.
    Buitendijk GH; Amin N; Hofman A; van Duijn CM; Vingerling JR; Klaver CC
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(10):6167-74. PubMed ID: 25146986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Risk, Lifestyle, and Age-Related Macular Degeneration in Europe: The EYE-RISK Consortium.
    Colijn JM; Meester-Smoor M; Verzijden T; de Breuk A; Silva R; Merle BMJ; Cougnard-Grégoire A; Hoyng CB; Fauser S; Coolen A; Creuzot-Garcher C; Hense HW; Ueffing M; Delcourt C; den Hollander AI; Klaver CCW;
    Ophthalmology; 2021 Jul; 128(7):1039-1049. PubMed ID: 33253757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of direct-to-consumer genetic testing on Australian clinical genetics services.
    Millward M; Tiller J; Bogwitz M; Kincaid H; Taylor S; Trainer AH; Lacaze P
    Eur J Med Genet; 2020 Sep; 63(9):103968. PubMed ID: 32502649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic screening for macular dystrophies in patients clinically diagnosed with dry age-related macular degeneration.
    Kersten E; Geerlings MJ; Pauper M; Corominas J; Bakker B; Altay L; Fauser S; de Jong EK; Hoyng CB; den Hollander AI
    Clin Genet; 2018 Dec; 94(6):569-574. PubMed ID: 30215852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Genotype Assay for Age-Related Macular Degeneration: The EYE-RISK Consortium.
    de Breuk A; Acar IE; Kersten E; Schijvenaars MMVAP; Colijn JM; Haer-Wigman L; Bakker B; de Jong S; Meester-Smoor MA; Verzijden T; Missotten TOAR; Monés J; Biarnés M; Pauleikhoff D; Hense HW; Silva R; Nunes S; Melo JB; Fauser S; Hoyng CB; Ueffing M; Coenen MJH; Klaver CCW; den Hollander AI;
    Ophthalmology; 2021 Nov; 128(11):1604-1617. PubMed ID: 32717343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole exome sequencing of extreme age-related macular degeneration phenotypes.
    Sardell RJ; Bailey JN; Courtenay MD; Whitehead P; Laux RA; Adams LD; Fortun JA; Brantley MA; Kovach JL; Schwartz SG; Agarwal A; Scott WK; Haines JL; Pericak-Vance MA
    Mol Vis; 2016; 22():1062-76. PubMed ID: 27625572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Informed choice in direct-to-consumer genetic testing (DTCGT) websites: a content analysis of benefits, risks, and limitations.
    Singleton A; Erby LH; Foisie KV; Kaphingst KA
    J Genet Couns; 2012 Jun; 21(3):433-9. PubMed ID: 22194036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-Exome Sequencing in Age-Related Macular Degeneration Identifies Rare Variants in COL8A1, a Component of Bruch's Membrane.
    Corominas J; Colijn JM; Geerlings MJ; Pauper M; Bakker B; Amin N; Lores Motta L; Kersten E; Garanto A; Verlouw JAM; van Rooij JGJ; Kraaij R; de Jong PTVM; Hofman A; Vingerling JR; Schick T; Fauser S; de Jong EK; van Duijn CM; Hoyng CB; Klaver CCW; den Hollander AI
    Ophthalmology; 2018 Sep; 125(9):1433-1443. PubMed ID: 29706360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractive Error Has Minimal Influence on the Risk of Age-Related Macular Degeneration: A Mendelian Randomization Study.
    Wood A; Guggenheim JA
    Am J Ophthalmol; 2019 Oct; 206():87-93. PubMed ID: 30905725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Risk in Families with Age-Related Macular Degeneration.
    de Breuk A; Lechanteur YTE; Heesterbeek TJ; Fauser S; Klaver CCW; Hoyng CB; den Hollander AI
    Ophthalmol Sci; 2021 Dec; 1(4):100087. PubMed ID: 36246952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related macular degeneration-clinical review and genetics update.
    Ratnapriya R; Chew EY
    Clin Genet; 2013 Aug; 84(2):160-6. PubMed ID: 23713713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary care patients' views and decisions about, experience of and reactions to direct-to-consumer genetic testing: a longitudinal study.
    Wasson K; Sanders TN; Hogan NS; Cherny S; Helzlsouer KJ
    J Community Genet; 2013 Oct; 4(4):495-505. PubMed ID: 23832288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifestyle Intervention Randomized Controlled Trial for Age-Related Macular Degeneration (AMD-Life): Study Design.
    de Koning-Backus APM; Kiefte-de Jong JC; van Rooij JGJ; Amd-Life Team ; Uitterlinden AG; Voortman TG; Meester-Smoor MA; Klaver CCW
    Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype.
    Sofat R; Casas JP; Webster AR; Bird AC; Mann SS; Yates JR; Moore AT; Sepp T; Cipriani V; Bunce C; Khan JC; Shahid H; Swaroop A; Abecasis G; Branham KE; Zareparsi S; Bergen AA; Klaver CC; Baas DC; Zhang K; Chen Y; Gibbs D; Weber BH; Keilhauer CN; Fritsche LG; Lotery A; Cree AJ; Griffiths HL; Bhattacharya SS; Chen LL; Jenkins SA; Peto T; Lathrop M; Leveillard T; Gorin MB; Weeks DE; Ortube MC; Ferrell RE; Jakobsdottir J; Conley YP; Rahu M; Seland JH; Soubrane G; Topouzis F; Vioque J; Tomazzoli L; Young I; Whittaker J; Chakravarthy U; de Jong PT; Smeeth L; Fletcher A; Hingorani AD
    Int J Epidemiol; 2012 Feb; 41(1):250-62. PubMed ID: 22253316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Making Biological Sense of Genetic Studies of Age-Related Macular Degeneration.
    Singh N; Swaroop A; Ratnapriya R
    Adv Exp Med Biol; 2021; 1256():201-219. PubMed ID: 33848003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards the application of precision medicine in Age-Related Macular Degeneration.
    Cascella R; Strafella C; Caputo V; Errichiello V; Zampatti S; Milano F; Potenza S; Mauriello S; Novelli G; Ricci F; Cusumano A; Giardina E
    Prog Retin Eye Res; 2018 Mar; 63():132-146. PubMed ID: 29197628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences.
    Seddon JM; Cote J; Page WF; Aggen SH; Neale MC
    Arch Ophthalmol; 2005 Mar; 123(3):321-7. PubMed ID: 15767473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rare Genetic Variants Associated With Development of Age-Related Macular Degeneration.
    Saksens NT; Geerlings MJ; Bakker B; Schick T; Daha MR; Fauser S; Boon CJ; de Jong EK; Hoyng CB; den Hollander AI
    JAMA Ophthalmol; 2016 Mar; 134(3):287-93. PubMed ID: 26767664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.